| REGN |
Regeneron Pharmaceuticals, Inc. |
123.47B |
6.06% |
|
|
|
|
|
1,138.81 |
-0.69% |
24.84% |
45.57% |
|---|
| AZN.L |
ASTRAZENECA PLC |
|
5.79% |
|
|
|
|
|
|
|
|
|
|---|
| MRK |
Merck & Co., Inc. |
300.73B |
4.39% |
|
|
|
|
|
118.64 |
0.30% |
23.08% |
31.38% |
|---|
| AMGN |
Amgen Inc. |
178.89B |
4.27% |
|
|
|
|
|
332.92 |
0.04% |
34.71% |
32.51% |
|---|
| ARGX |
argenx SE |
31.64B |
4.03% |
|
|
|
|
|
529.06 |
1.31% |
27.65% |
5.72% |
|---|
| 4568.T |
DAIICHI SANKYO CO., LTD. |
|
3.74% |
|
|
|
|
|
|
|
|
|
|---|
| 4519.T |
CHUGAI PHARMACEUTICAL CO., LTD. |
|
3.36% |
|
|
|
|
|
|
|
|
|
|---|
| ILMN |
Illumina, Inc. |
20.86B |
3.32% |
|
|
|
|
|
130.97 |
0.58% |
40.75% |
14.46% |
|---|
| RVMD |
Revolution Medicines, Inc. |
7.36B |
3.26% |
|
|
|
|
|
44.06 |
0.66% |
59.42% |
27.24% |
|---|
| BPMC |
Blueprint Medicines Corporation |
5.66B |
3.25% |
|
|
|
|
|
89.33 |
3.26% |
45.52% |
27.76% |
|---|
| GILD |
Gilead Sciences, Inc. |
104.44B |
3.10% |
|
|
|
|
|
83.89 |
1.01% |
35.26% |
25.40% |
|---|
| MREO |
Mereo BioPharma Group plc |
739.24M |
2.77% |
|
|
|
|
|
4.22 |
6.84% |
75.98% |
38.48% |
|---|
| INCY |
Incyte Corporation |
12.55B |
2.77% |
|
|
|
|
|
65.17 |
-1.90% |
31.85% |
48.32% |
|---|
| NOVN.SW |
NOVARTIS AG |
|
2.65% |
|
|
|
|
|
|
|
|
|
|---|
| LEGN |
Legend Biotech Corporation |
9.14B |
2.56% |
|
|
|
|
|
49.91 |
-2.46% |
58.70% |
45.72% |
|---|
| BGNE |
BeiGene, Ltd. |
22.83B |
2.44% |
|
|
|
|
|
197.28 |
-0.12% |
33.41% |
14.07% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
2.29B |
2.40% |
|
|
|
|
|
22.52 |
-0.13% |
67.43% |
43.97% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
2.77B |
2.29% |
|
|
|
|
|
41.85 |
1.48% |
98.96% |
51.55% |
|---|
| GMAB |
Genmab A/S |
16.64B |
2.26% |
|
|
|
|
|
26.20 |
-0.87% |
102.04% |
29.36% |
|---|
| CRSP |
CRISPR Therapeutics AG |
4.22B |
2.09% |
|
|
|
|
|
49.59 |
-0.56% |
57.06% |
18.69% |
|---|
| EXEL |
Exelixis, Inc. |
7.65B |
2.06% |
|
|
|
|
|
26.82 |
-2.83% |
52.36% |
41.28% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
2.59B |
2.03% |
|
|
|
|
|
45.54 |
-0.33% |
65.65% |
75.33% |
|---|
| EXAS |
Exact Sciences Corporation |
12.79B |
1.89% |
|
|
|
|
|
69.21 |
1.79% |
73.36% |
22.15% |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
1.21B |
1.81% |
|
|
|
|
|
13.79 |
0.22% |
98.04% |
15.16% |
|---|
| NUVL |
Nuvalent, Inc. |
6.65B |
1.76% |
|
|
|
|
|
102.63 |
-2.02% |
37.00% |
-5.92% |
|---|
| ACLX |
Arcellx, Inc. |
4.33B |
1.66% |
|
|
|
|
|
80.55 |
3.28% |
49.77% |
35.22% |
|---|
| SWTX |
SpringWorks Therapeutics, Inc. |
2.64B |
1.62% |
|
|
|
|
|
35.58 |
0.45% |
52.22% |
24.19% |
|---|
| GH |
Guardant Health, Inc. |
3.09B |
1.57% |
|
|
|
|
|
25.08 |
-0.04% |
88.83% |
49.60% |
|---|
| LNTH |
Lantheus Holdings, Inc. |
7.51B |
1.50% |
|
|
|
|
|
108.14 |
2.46% |
60.22% |
49.58% |
|---|
| SHL.DE |
SIEMENS HEALTHINEERS AG |
|
1.49% |
|
|
|
|
|
|
|
|
|
|---|
| MRUS |
Merus N.V. |
3.37B |
1.30% |
|
|
|
|
|
49.42 |
-1.36% |
46.43% |
10.62% |
|---|
| MRNA |
Moderna, Inc. |
26.85B |
1.24% |
|
|
|
|
|
69.86 |
-2.96% |
77.97% |
75.53% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
1.51B |
1.18% |
|
|
|
|
|
16.49 |
-1.43% |
166.57% |
64.64% |
|---|
| JANX |
Janux Therapeutics, Inc. |
2.52B |
1.15% |
|
|
|
|
|
48.32 |
-2.30% |
99.76% |
45.54% |
|---|
| SDGR |
Schrödinger, Inc. |
1.44B |
1.15% |
|
|
|
|
|
19.72 |
0.51% |
62.68% |
29.53% |
|---|
| CRBP |
Corbus Pharmaceuticals Holdings, Inc. |
594.13M |
1.10% |
|
|
|
|
|
49.33 |
-3.08% |
192.00% |
105.21% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
2.94B |
1.07% |
|
|
|
|
|
34.75 |
-2.88% |
76.90% |
66.55% |
|---|
| COGT |
Cogent Biosciences, Inc. |
1.15B |
1.04% |
|
|
|
|
|
10.55 |
0.29% |
102.04% |
13.83% |
|---|
| CGEM |
Cullinan Oncology, Inc. |
998.94M |
0.91% |
|
|
|
|
|
17.23 |
-0.06% |
169.98% |
26.45% |
|---|
| RLAY |
Relay Therapeutics, Inc. |
1.23B |
0.75% |
|
|
|
|
|
7.58 |
-0.26% |
39.56% |
6.40% |
|---|
| BCYC |
Bicycle Therapeutics plc |
1.68B |
0.72% |
|
|
|
|
|
24.36 |
-0.20% |
127.08% |
64.61% |
|---|
| IMCR |
Immunocore Holdings plc |
1.72B |
0.69% |
|
|
|
|
|
34.44 |
1.59% |
62.55% |
47.76% |
|---|
| ARVN |
Arvinas, Inc. |
1.71B |
0.68% |
|
|
|
|
|
24.97 |
-1.38% |
74.07% |
21.88% |
|---|
| TERN |
Terns Pharmaceuticals, Inc. |
862.09M |
0.64% |
|
|
|
|
|
10.21 |
6.02% |
122.13% |
12.32% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
2.49B |
0.56% |
|
|
|
|
|
37.06 |
-1.83% |
79.87% |
16.72% |
|---|
| JSPR |
Jasper Therapeutics, Inc. |
343.49M |
0.43% |
|
|
|
|
|
22.74 |
-1.00% |
121.14% |
28.69% |
|---|
| FATE |
Fate Therapeutics, Inc. |
441.85M |
0.36% |
|
|
|
|
|
3.88 |
-3.00% |
127.11% |
6.23% |
|---|